United States Seasonal Influenza Vaccine Market Report 2018
In this report, the United States Seasonal Influenza Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
Geographically, this report splits the United States market into seven regions:
- The West
- Southwest
- The Middle Atlantic
- New England
- The South
- The Midwest
- with sales (volume), revenue (value), market share and growth rate of Seasonal Influenza Vaccine in these regions, from 2013 to 2025 (forecast).
- GSK
- Sinovac
- Changsheng
- CCBIO
- Aleph Biomedical
- Sanofi
- Lanzhou Institute Of Biological Product
- Siobp
- Hualan Bio
- Tianyuan Bio-Pharma
- Vaxtec
- Hissen
- Abbott
- Novartis
- Tasly&Jenner
- Tiantan
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- Other
- Children
- Adults
- Elderly
- Pregnancy
United States Seasonal Influenza Vaccine Market Report 2018
1 SEASONAL INFLUENZA VACCINE OVERVIEW
1.1 Product Overview and Scope of Seasonal Influenza Vaccine
1.2 Classification of Seasonal Influenza Vaccine by Product Category
1.2.1 United States Seasonal Influenza Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Seasonal Influenza Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Trivalent Influenza Vaccine
1.2.4 Quadrivalent Influenza Vaccine
1.2.5 Other
1.3 United States Seasonal Influenza Vaccine Market by Application/End Users
1.3.1 United States Seasonal Influenza Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.3.5 Pregnancy
1.4 United States Seasonal Influenza Vaccine Market by Region
1.4.1 United States Seasonal Influenza Vaccine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.3 Southwest Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.5 New England Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.6 The South Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.7 The Midwest Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Seasonal Influenza Vaccine (2013-2025)
1.5.1 United States Seasonal Influenza Vaccine Sales and Growth Rate (2013-2025)
1.5.2 United States Seasonal Influenza Vaccine Revenue and Growth Rate (2013-2025)
2 UNITED STATES SEASONAL INFLUENZA VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS
2.1 United States Seasonal Influenza Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Seasonal Influenza Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Seasonal Influenza Vaccine Average Price by Players/Suppliers (2013-2018)
2.4 United States Seasonal Influenza Vaccine Market Competitive Situation and Trends
2.4.1 United States Seasonal Influenza Vaccine Market Concentration Rate
2.4.2 United States Seasonal Influenza Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Seasonal Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
3 UNITED STATES SEASONAL INFLUENZA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)
3.1 United States Seasonal Influenza Vaccine Sales and Market Share by Region (2013-2018)
3.2 United States Seasonal Influenza Vaccine Revenue and Market Share by Region (2013-2018)
3.3 United States Seasonal Influenza Vaccine Price by Region (2013-2018)
4 UNITED STATES SEASONAL INFLUENZA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)
4.1 United States Seasonal Influenza Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Seasonal Influenza Vaccine Revenue and Market Share by Type (2013-2018)
4.3 United States Seasonal Influenza Vaccine Price by Type (2013-2018)
4.4 United States Seasonal Influenza Vaccine Sales Growth Rate by Type (2013-2018)
5 UNITED STATES SEASONAL INFLUENZA VACCINE SALES (VOLUME) BY APPLICATION (2013-2018)
5.1 United States Seasonal Influenza Vaccine Sales and Market Share by Application (2013-2018)
5.2 United States Seasonal Influenza Vaccine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 UNITED STATES SEASONAL INFLUENZA VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Sinovac
6.2.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sinovac Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Changsheng
6.3.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Changsheng Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 CCBIO
6.4.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 CCBIO Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Aleph Biomedical
6.5.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Sanofi
6.6.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Lanzhou Institute Of Biological Product
6.7.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Siobp
6.8.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Siobp Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Hualan Bio
6.9.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hualan Bio Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Tianyuan Bio-Pharma
6.10.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Vaxtec
6.12 Hissen
6.13 Abbott
6.14 Novartis
6.15 Tasly&Jenner
6.16 Tiantan
7 SEASONAL INFLUENZA VACCINE MANUFACTURING COST ANALYSIS
7.1 Seasonal Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Seasonal Influenza Vaccine
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Seasonal Influenza Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES SEASONAL INFLUENZA VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)
11.1 United States Seasonal Influenza Vaccine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Seasonal Influenza Vaccine Sales Volume Forecast by Type (2018-2025)
11.3 United States Seasonal Influenza Vaccine Sales Volume Forecast by Application (2018-2025)
11.4 United States Seasonal Influenza Vaccine Sales Volume Forecast by Region (2018-2025)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 SEASONAL INFLUENZA VACCINE OVERVIEW
1.1 Product Overview and Scope of Seasonal Influenza Vaccine
1.2 Classification of Seasonal Influenza Vaccine by Product Category
1.2.1 United States Seasonal Influenza Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Seasonal Influenza Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Trivalent Influenza Vaccine
1.2.4 Quadrivalent Influenza Vaccine
1.2.5 Other
1.3 United States Seasonal Influenza Vaccine Market by Application/End Users
1.3.1 United States Seasonal Influenza Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.3.5 Pregnancy
1.4 United States Seasonal Influenza Vaccine Market by Region
1.4.1 United States Seasonal Influenza Vaccine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.3 Southwest Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.5 New England Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.6 The South Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.4.7 The Midwest Seasonal Influenza Vaccine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Seasonal Influenza Vaccine (2013-2025)
1.5.1 United States Seasonal Influenza Vaccine Sales and Growth Rate (2013-2025)
1.5.2 United States Seasonal Influenza Vaccine Revenue and Growth Rate (2013-2025)
2 UNITED STATES SEASONAL INFLUENZA VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS
2.1 United States Seasonal Influenza Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Seasonal Influenza Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Seasonal Influenza Vaccine Average Price by Players/Suppliers (2013-2018)
2.4 United States Seasonal Influenza Vaccine Market Competitive Situation and Trends
2.4.1 United States Seasonal Influenza Vaccine Market Concentration Rate
2.4.2 United States Seasonal Influenza Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Seasonal Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
3 UNITED STATES SEASONAL INFLUENZA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)
3.1 United States Seasonal Influenza Vaccine Sales and Market Share by Region (2013-2018)
3.2 United States Seasonal Influenza Vaccine Revenue and Market Share by Region (2013-2018)
3.3 United States Seasonal Influenza Vaccine Price by Region (2013-2018)
4 UNITED STATES SEASONAL INFLUENZA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)
4.1 United States Seasonal Influenza Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Seasonal Influenza Vaccine Revenue and Market Share by Type (2013-2018)
4.3 United States Seasonal Influenza Vaccine Price by Type (2013-2018)
4.4 United States Seasonal Influenza Vaccine Sales Growth Rate by Type (2013-2018)
5 UNITED STATES SEASONAL INFLUENZA VACCINE SALES (VOLUME) BY APPLICATION (2013-2018)
5.1 United States Seasonal Influenza Vaccine Sales and Market Share by Application (2013-2018)
5.2 United States Seasonal Influenza Vaccine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 UNITED STATES SEASONAL INFLUENZA VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Sinovac
6.2.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sinovac Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Changsheng
6.3.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Changsheng Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 CCBIO
6.4.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 CCBIO Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Aleph Biomedical
6.5.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Sanofi
6.6.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Lanzhou Institute Of Biological Product
6.7.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Siobp
6.8.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Siobp Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Hualan Bio
6.9.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hualan Bio Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Tianyuan Bio-Pharma
6.10.2 Seasonal Influenza Vaccine Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Vaxtec
6.12 Hissen
6.13 Abbott
6.14 Novartis
6.15 Tasly&Jenner
6.16 Tiantan
7 SEASONAL INFLUENZA VACCINE MANUFACTURING COST ANALYSIS
7.1 Seasonal Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Seasonal Influenza Vaccine
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Seasonal Influenza Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES SEASONAL INFLUENZA VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)
11.1 United States Seasonal Influenza Vaccine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Seasonal Influenza Vaccine Sales Volume Forecast by Type (2018-2025)
11.3 United States Seasonal Influenza Vaccine Sales Volume Forecast by Application (2018-2025)
11.4 United States Seasonal Influenza Vaccine Sales Volume Forecast by Region (2018-2025)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of Seasonal Influenza Vaccine
Figure United States Seasonal Influenza Vaccine Market Size (K Doses) by Type (2013-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure United States Seasonal Influenza Vaccine Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Seasonal Influenza Vaccine by Application in 2017
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure United States Seasonal Influenza Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Seasonal Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Seasonal Influenza Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Seasonal Influenza Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Seasonal Influenza Vaccine Sales Share by Players/Suppliers
Figure United States Seasonal Influenza Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Seasonal Influenza Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Seasonal Influenza Vaccine Revenue Share by Players/Suppliers
Table United States Market Seasonal Influenza Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Seasonal Influenza Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Seasonal Influenza Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Seasonal Influenza Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Seasonal Influenza Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Seasonal Influenza Vaccine Product Category
Table United States Seasonal Influenza Vaccine Sales (K Doses) by Region (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Region in 2017
Table United States Seasonal Influenza Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Revenue Market Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Revenue Market Share by Region in 2017
Table United States Seasonal Influenza Vaccine Price (USD/Dose) by Region (2013-2018)
Table United States Seasonal Influenza Vaccine Sales (K Doses) by Type (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Share by Type (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Share by Type (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Type in 2017
Table United States Seasonal Influenza Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Seasonal Influenza Vaccine by Type (2013-2018)
Figure Revenue Market Share of Seasonal Influenza Vaccine by Type in 2017
Table United States Seasonal Influenza Vaccine Price (USD/Dose) by Types (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Growth Rate by Type (2013-2018)
Table United States Seasonal Influenza Vaccine Sales (K Doses) by Application (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Application in 2017
Table United States Seasonal Influenza Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Growth Rate by Application (2013-2018)
Table GSK Basic Information List
Table GSK Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GSK Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure GSK Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure GSK Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Sinovac Basic Information List
Table Sinovac Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sinovac Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Sinovac Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Sinovac Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Changsheng Basic Information List
Table Changsheng Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Changsheng Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Changsheng Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Changsheng Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table CCBIO Basic Information List
Table CCBIO Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure CCBIO Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure CCBIO Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure CCBIO Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Aleph Biomedical Basic Information List
Table Aleph Biomedical Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Aleph Biomedical Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Aleph Biomedical Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Aleph Biomedical Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Sanofi Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Lanzhou Institute Of Biological Product Basic Information List
Table Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Siobp Basic Information List
Table Siobp Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Siobp Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Siobp Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Siobp Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Hualan Bio Basic Information List
Table Hualan Bio Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Hualan Bio Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Hualan Bio Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Hualan Bio Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Tianyuan Bio-Pharma Basic Information List
Table Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Vaxtec Basic Information List
Table Hissen Basic Information List
Table Abbott Basic Information List
Table Novartis Basic Information List
Table Tasly&Jenner Basic Information List
Table Tiantan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Seasonal Influenza Vaccine
Figure Manufacturing Process Analysis of Seasonal Influenza Vaccine
Figure Seasonal Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Seasonal Influenza Vaccine Major Players/Suppliers in 2017
Table Major Buyers of Seasonal Influenza Vaccine
Table Distributors/Traders List
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Seasonal Influenza Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Type in 2025
Table United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Application in 2025
Table United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Seasonal Influenza Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Seasonal Influenza Vaccine
Figure United States Seasonal Influenza Vaccine Market Size (K Doses) by Type (2013-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure United States Seasonal Influenza Vaccine Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Seasonal Influenza Vaccine by Application in 2017
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure United States Seasonal Influenza Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Seasonal Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Seasonal Influenza Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Seasonal Influenza Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Seasonal Influenza Vaccine Sales Share by Players/Suppliers
Figure United States Seasonal Influenza Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Seasonal Influenza Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Seasonal Influenza Vaccine Revenue Share by Players/Suppliers
Table United States Market Seasonal Influenza Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Seasonal Influenza Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Seasonal Influenza Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Seasonal Influenza Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Seasonal Influenza Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Seasonal Influenza Vaccine Product Category
Table United States Seasonal Influenza Vaccine Sales (K Doses) by Region (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Region in 2017
Table United States Seasonal Influenza Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Revenue Market Share by Region (2013-2018)
Figure United States Seasonal Influenza Vaccine Revenue Market Share by Region in 2017
Table United States Seasonal Influenza Vaccine Price (USD/Dose) by Region (2013-2018)
Table United States Seasonal Influenza Vaccine Sales (K Doses) by Type (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Share by Type (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Share by Type (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Type in 2017
Table United States Seasonal Influenza Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Seasonal Influenza Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Seasonal Influenza Vaccine by Type (2013-2018)
Figure Revenue Market Share of Seasonal Influenza Vaccine by Type in 2017
Table United States Seasonal Influenza Vaccine Price (USD/Dose) by Types (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Growth Rate by Type (2013-2018)
Table United States Seasonal Influenza Vaccine Sales (K Doses) by Application (2013-2018)
Table United States Seasonal Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Market Share by Application in 2017
Table United States Seasonal Influenza Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States Seasonal Influenza Vaccine Sales Growth Rate by Application (2013-2018)
Table GSK Basic Information List
Table GSK Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GSK Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure GSK Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure GSK Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Sinovac Basic Information List
Table Sinovac Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sinovac Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Sinovac Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Sinovac Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Changsheng Basic Information List
Table Changsheng Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Changsheng Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Changsheng Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Changsheng Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table CCBIO Basic Information List
Table CCBIO Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure CCBIO Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure CCBIO Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure CCBIO Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Aleph Biomedical Basic Information List
Table Aleph Biomedical Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Aleph Biomedical Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Aleph Biomedical Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Aleph Biomedical Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Sanofi Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Lanzhou Institute Of Biological Product Basic Information List
Table Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Siobp Basic Information List
Table Siobp Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Siobp Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Siobp Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Siobp Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Hualan Bio Basic Information List
Table Hualan Bio Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Hualan Bio Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Hualan Bio Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Hualan Bio Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Tianyuan Bio-Pharma Basic Information List
Table Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales Growth Rate (2013-2018)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales Market Share in United States (2013-2018)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Revenue Market Share in United States (2013-2018)
Table Vaxtec Basic Information List
Table Hissen Basic Information List
Table Abbott Basic Information List
Table Novartis Basic Information List
Table Tasly&Jenner Basic Information List
Table Tiantan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Seasonal Influenza Vaccine
Figure Manufacturing Process Analysis of Seasonal Influenza Vaccine
Figure Seasonal Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Seasonal Influenza Vaccine Major Players/Suppliers in 2017
Table Major Buyers of Seasonal Influenza Vaccine
Table Distributors/Traders List
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Seasonal Influenza Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Type in 2025
Table United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Application in 2025
Table United States Seasonal Influenza Vaccine Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Seasonal Influenza Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Seasonal Influenza Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025.
The report offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market. The report includes historic data from 2013 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the united states influenza vaccines market. The report also explores detailed analysis of number of children and adults vaccinated with influenza vaccines in United States from 2013 to 2017 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in United States.
A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of influenza vaccines in United States. It also provides a deep and thorough evaluation of distribution channel & technique of influenza vaccination. It covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States influenza vaccines market.
The report concludes with the profiles of major players in the United States influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development of influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which is likely to affect the market share during the forecast period.
Key questions answered in this research report:
• At what pace is the influenza vaccines market growing in United States? What will be growth trend in future?
• How much number of persons being vaccinated with influenza vaccines during 2013 - 2025?
• What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future?
• What are the various influenza vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
